Amdocs Limited (NASDAQ:DOX - Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 3,950,000 shares, an increase of 15.5% from the January 15th total of 3,420,000 shares. Currently, 3.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 714,200 shares, the days-to-cover ratio is currently 5.5 days.
Amdocs Stock Performance
Shares of NASDAQ DOX traded down $1.40 during midday trading on Friday, hitting $87.91. The company's stock had a trading volume of 726,643 shares, compared to its average volume of 651,589. Amdocs has a 1-year low of $74.41 and a 1-year high of $94.04. The firm's fifty day moving average price is $86.06 and its 200-day moving average price is $86.56. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The firm has a market cap of $9.92 billion, a P/E ratio of 20.40, a P/E/G ratio of 1.48 and a beta of 0.71.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, sell-side analysts forecast that Amdocs will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Sunday, April 20th. Shareholders of record on Monday, March 31st will be paid a $0.527 dividend. The ex-dividend date of this dividend is Monday, March 31st. This is a boost from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a yield of 2.40%. Amdocs's payout ratio is 44.55%.
Wall Street Analysts Forecast Growth
DOX has been the subject of a number of research analyst reports. Barclays dropped their price target on Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research report on Thursday, November 14th. StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Wednesday. Finally, Oppenheimer raised their price target on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $101.20.
Get Our Latest Research Report on DOX
Institutional Trading of Amdocs
Institutional investors and hedge funds have recently modified their holdings of the company. Private Trust Co. NA raised its stake in Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock valued at $27,000 after purchasing an additional 117 shares during the last quarter. Brooklyn Investment Group bought a new stake in shares of Amdocs in the 3rd quarter worth about $28,000. Jones Financial Companies Lllp bought a new stake in shares of Amdocs in the 4th quarter worth about $36,000. SBI Securities Co. Ltd. bought a new stake in shares of Amdocs in the 4th quarter worth about $41,000. Finally, Global Retirement Partners LLC grew its holdings in shares of Amdocs by 45.6% in the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock worth $48,000 after purchasing an additional 175 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.
Amdocs Company Profile
(
Get Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.